## CNC: Centene Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 2.2% below STRENGTH zone (3.0-6.0%); PEG 1.67 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($36.00)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 2)

**1. Why Centene (CNC) Shares Are Sliding Today**
- Source: Finviz | 20251216T212446 | Bearish | Relevance: 100%
- Centene (NYSE:CNC) shares fell 4.3% due to concerns that the House Speaker would block a vote to renew premium subsidies for the Affordable Care Act, significantly impacting the company as a key provider of government-backed health plans. This news, combined with existing pressures from rising medical expenses, casts uncertainty on Centene's future earnings and enrollment. Despite the drop, previous reports indicated positive sentiment from investment firms and funds, but the stock is down 35.6% year-to-date.

**2. Ambetter Health & Tampa Bay Buccaneers Launch "Stay Healthy, Stay in the Game" PSA Urging Floridians to Prioritize Preventive Care Before Year-End – Company Announcement - FT.com**
- Source: Financial Times | 20251217T200100 | Bullish | Relevance: 100%
- Ambetter Health and the Tampa Bay Buccaneers have collaborated on a new public service announcement (PSA) called "Stay Healthy, Stay in the Game." This campaign encourages Floridians to prioritize preventive care, routine screenings, and year-end checkups, featuring Buccaneers players who highlight the importance of proactive health management. The initiative aims to motivate individuals to take charge of their health for a better quality of life.

**3. Paralympian Dana Mathewson joins new campaign to boost Florida health**
- Source: Stock Titan | 20251217T180154 | Bullish | Relevance: 100%
- Sunshine Health, a Centene Corporation company, announced a partnership with elite female athletes, including Paralympian Dana Mathewson, to promote health awareness across Florida. This collaboration with sports marketing partner Parity focuses on prevention, mental health, child and maternal health, and community wellness. Sunshine Health will utilize its 10 Community Connections Centers to provide outreach, education, and resources to Medicaid members statewide.

**4. Centene Corp. Stock Falls 3.7%, Underperforms Peers**
- Source: 富途牛牛 | 20251217T120809 | Bearish | Relevance: 100%
- Centene Corp. (CNC) saw its stock fall by 3.7%, underperforming its peers. The article also briefly mentions Unity Software's (U.US) fourth-quarter earnings, where revenue increased 35% year-over-year to $609 million, though the company reported a quarterly loss of 66 cents per share.

**5. Arizona court weighs Centene bid to force provider case to arbitration**
- Source: Beinsure | 20251215T180951 | Somewhat-Bearish | Relevance: 100%
- The Superior Court of Arizona is considering whether a discrimination lawsuit filed against Centene Corp. should be moved to arbitration. Centene's affiliate, Arizona Complete Health, argues that their contracts with healthcare providers mandate arbitration for dispute resolution. The underlying lawsuit alleges that state agencies and insurers, including Centene, discriminated against healthcare providers serving Native American populations by targeting them in fraud investigations that allegedly lacked proper investigation and caused reputational damage.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | Bernstein | $45 | $36 | +25% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | Bernstein | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.00M) |
| Sells | 2 ($2.58M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.6% (-2.8%)
- Blackrock Inc.: 9.2% (+0.3%)
- State Street Corpora: 4.3% (-7.7%)
- AQR Capital Manageme: 3.0% (+76.6%)
- Geode Capital Manage: 2.6% (-4.8%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-1.9% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 11.0% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.67 elevated, pricing in significant growth expectations. Forward P/E 13.4x attractive for 43% earnings growth. Balance sheet: $1.1B free cash flow. Analyst sentiment positive (1 raises, avg +25%). Insider selling cluster ($2.6M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.1B |
| Beta | 0.48 |
| 52W Range | $25.08 - $66.81 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.67 |
| Forward P/E | 13.4 |
| Current P/E | 19.2 |
| YoY Growth | 43.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 4.1% to 2.2% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.8pp (needs >3.0% for momentum thesis). MRS_5 (-0.7%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.89x), long-term trend not supportive. RSI neutral at 54. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.17% (CS: 46) | Neutral |
| RSI_14 | 53.6 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 1.052x | Above |
| vs SMA200 | 0.890x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $38.88
- **Stop Loss:** $36.00 (7.4% risk)
- **Target:** $41.76 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 374
- **Position Value:** $14,541.12
- **Portfolio %:** 14.54%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-03 (Est: $-1.19)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.16 | $0.50 | +404.3% |
| 2025Q2 | $0.21 | $-0.16 | -177.3% |
| 2025Q1 | $2.52 | $2.90 | +15.3% |
| 2024Q4 | $0.49 | $0.80 | +62.2% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*